| Autor: |
L.F. Matyukha, T. A. Titova |
| Rok vydání: |
2018 |
| Předmět: |
|
| Zdroj: |
Likarska sprava. :109-118 |
| ISSN: |
1019-5297 |
| DOI: |
10.31640/jvd.7-8.2018(19) |
| Popis: |
The usage effectiveness of oral antimicrobial drug Flaprox was studied and the dynamics of clinical and laboratory indicators were compared versus with nitrofurans therapy in patients with exacerbation of chronic urinary tract infections on an outpatient basis were evaluated. Thеrе were investigated the results of treatment of 40 patients at the age (39.8 ± 8.9) years with exacerbation of chronic pyelonephritis. Patients of the І group (26 persons) received Flaprox 500 mg twice a day 10 days long, group II (14 persons) – nitrofuran 0.1 g 4 times a day 10 days long. The clinical manifestations regression of urinary tract infection in the research/study process was noted in both groups. In the group I, the dynamics of reduction of symptoms of general intoxication and normalization of local symptoms and inflammatory changes in blood and urine has a more pronounced tendency from 5 days of treatment and persisted throughout the course of therapy. Flaprox useing for 10 days allowed to reliably reduce or eliminate dysuria, infection of the urinary tract (bacteriuria), and inflammatory process (leukocythria) without negative changes in the blood biochemistry analysis. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
